RU2019132181A - METHOD FOR COMBATING VIRAL INFECTIONS - Google Patents

METHOD FOR COMBATING VIRAL INFECTIONS Download PDF

Info

Publication number
RU2019132181A
RU2019132181A RU2019132181A RU2019132181A RU2019132181A RU 2019132181 A RU2019132181 A RU 2019132181A RU 2019132181 A RU2019132181 A RU 2019132181A RU 2019132181 A RU2019132181 A RU 2019132181A RU 2019132181 A RU2019132181 A RU 2019132181A
Authority
RU
Russia
Prior art keywords
benzydamine hydrochloride
antiviral
viral infections
hydrochloride
benzydamine
Prior art date
Application number
RU2019132181A
Other languages
Russian (ru)
Other versions
RU2019132181A3 (en
RU2749968C2 (en
Original Assignee
Кукес Илья Владимирович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кукес Илья Владимирович filed Critical Кукес Илья Владимирович
Priority to RU2019132181A priority Critical patent/RU2749968C2/en
Publication of RU2019132181A3 publication Critical patent/RU2019132181A3/ru
Publication of RU2019132181A publication Critical patent/RU2019132181A/en
Application granted granted Critical
Publication of RU2749968C2 publication Critical patent/RU2749968C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (6)

1. Способ борьбы с респираторными вирусами и вирусами, поражающими кожу и слизистые, включающий местное применение противовирусного препарата на целевые поверхности, отличающийся тем, что в качестве противовирусного препарата применяют препарат, включающий бензидамина гидрохлорид, используя его противовирусные, антибактериальные, противогрибковые, противовоспалительные и анальгезирующие свойства.1. A method of combating respiratory viruses and viruses that infect the skin and mucous membranes, including the local application of an antiviral drug to target surfaces, characterized in that a drug containing benzydamine hydrochloride is used as an antiviral drug, using its antiviral, antibacterial, antifungal, anti-inflammatory and analgesic properties. 2. Способ по п. 1, отличающийся тем, что противовирусный препарат дополнительно к бензидамина гидрохлориду включает антимикробные средства.2. The method according to claim 1, characterized in that the antiviral preparation, in addition to benzydamine hydrochloride, comprises antimicrobial agents. 3. Способ по п. 1 или 2, отличающийся тем, что бензидамин гидрохлорид применяют в твердой, мягкой, жидкой или газообразной форме, с конечной концентрацией бензидамина гидрохлорида на целевой поверхности не менее 10,0 мкг/мл.3. The method according to claim 1 or 2, characterized in that benzydamine hydrochloride is used in solid, soft, liquid or gaseous form, with a final concentration of benzydamine hydrochloride on the target surface of at least 10.0 μg / ml. 4. Способ по п. 3, отличающийся тем, что раствор бензидамина гидрохлорида распыляют на поверхности дыхательных путей или поверхности слизистой.4. The method according to claim 3, characterized in that the solution of benzydamine hydrochloride is sprayed onto the surface of the respiratory tract or the surface of the mucous membrane. 5. Способ по п. 3, отличающийся тем, что бензидамина гидрохлорид наносят на поверхности кожи и слизистой аппликатором.5. The method according to claim 3, characterized in that benzydamine hydrochloride is applied to the surface of the skin and mucous membrane with an applicator. 6. Способ по пп. 1 и 2, отличающийся тем, что бензидамина гидрохлорид применяют в виде порошка.6. The method according to PP. 1 and 2, characterized in that benzydamine hydrochloride is used in powder form.
RU2019132181A 2019-10-11 2019-10-11 Method for viral infection control RU2749968C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2019132181A RU2749968C2 (en) 2019-10-11 2019-10-11 Method for viral infection control

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019132181A RU2749968C2 (en) 2019-10-11 2019-10-11 Method for viral infection control

Publications (3)

Publication Number Publication Date
RU2019132181A3 RU2019132181A3 (en) 2021-04-12
RU2019132181A true RU2019132181A (en) 2021-04-12
RU2749968C2 RU2749968C2 (en) 2021-06-21

Family

ID=75495531

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019132181A RU2749968C2 (en) 2019-10-11 2019-10-11 Method for viral infection control

Country Status (1)

Country Link
RU (1) RU2749968C2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464060B (en) * 1989-06-13 1991-03-04 Gunnar Swanbeck USE OF PENTANDIOL OR HEXANDIOL FOR THE PREPARATION OF AN AGENT FOR TREATMENT OF INFECTIONS CAUSED BY HERPESVIRUS
RU2114611C1 (en) * 1995-12-21 1998-07-10 Валентина Васильевна Малиновская Ointment
CN103893171B (en) * 2014-04-19 2016-05-25 武汉胜达康生物科技有限公司 The application of benzydamine hydrochloride in preparation treatment or flu-prevention virus infective medicament

Also Published As

Publication number Publication date
RU2019132181A3 (en) 2021-04-12
RU2749968C2 (en) 2021-06-21

Similar Documents

Publication Publication Date Title
HRP20230274T1 (en) Chemical compounds
FI3597646T3 (en) Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
RU2019114665A (en) ANTI-VIRAL COMPOSITIONS FOR TREATMENT OF INFECTIONS ASSOCIATED WITH CORONAVIRUSES
JP2011520992A5 (en)
JP2007513959A5 (en)
JP2019194191A5 (en)
MX2022012359A (en) Formulation.
WO2022015573A3 (en) Sars-cov-2 antigen-binding proteins and uses thereof
AR119031A1 (en) BROAD SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS THAT INCLUDE LYSOZIME AND METHODS OF USE OF THE SAME
RU2008110933A (en) APPLICATION OF AMBROXOL FOR TREATMENT OF RINOVIRAL INFECTIONS
RU2011122513A (en) COMPOSITION FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
WO2019108021A3 (en) Pharmaceutical composition comprising tofacitinib
FI3848028T3 (en) Methods of treating ocular conditions
BR112023000142A2 (en) BENZODIAZEPINE DERIVATIVES USEFUL IN THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION
JP2006507295A5 (en)
RU2019132181A (en) METHOD FOR COMBATING VIRAL INFECTIONS
RU2009144286A (en) COMPOSITIONS WITH N-HALOGENICATED AMINO ACID AND ANTI-INFLAMMATORY COMPOUNDS
WO2021205026A3 (en) Pharmaceutical composition for treatment of enveloped dna or rna virus induced infections and disorders
BRPI0918593A2 (en) pharmaceutical composition for use in the treatment of sexually transmitted infections
JP2018507847A5 (en)
RU2013142445A (en) PHARMACEUTICAL PRODUCT FOR LOCAL USE CONTAINING V-220
EP4285910A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NERVE INFECTIONS WITH ELEUTHEROSIDE B AS ACTIVE INGREDIENT
RU2013105211A (en) APPLICATION OF TERAPEPTIDE Arg-Pro-Gly-Pro AS A MEANS FOR PREVENTION AND TREATMENT OF HYPERCHOLESTERINEMIA, METHOD FOR PREVENTION AND TREATMENT OF HYPERCHOLESTEREMIA, PHARMACEUTICAL CHEMISTROSIS
WO2020139163A3 (en) Combination of antiviral agents
JP2020040998A5 (en)

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant